Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry
Top Cited Papers
- 1 July 2011
- journal article
- research article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 10 (7), 609-617
- https://doi.org/10.1016/s1474-4422(11)70107-7
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of ageBrain, 2011
- Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid?Pharmacoepidemiology and Drug Safety, 2010
- Pregnancy registries: Differences, similarities, and possible harmonizationEpilepsia, 2010
- Utilization of antiepileptic drugs during pregnancy: Comparative patterns in 38 countries based on data from the EURAP registryEpilepsia, 2009
- Pregnancy, delivery, and outcome for the child in maternal epilepsyEpilepsia, 2009
- Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic DrugsNew England Journal of Medicine, 2009
- Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK Epilepsy and Pregnancy RegisterJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Pregnancy outcomes in women with epilepsy: A systematic review and meta-analysis of published pregnancy registries and cohortsEpilepsy Research, 2008
- Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancyNeurology, 2008
- The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trialThe Lancet, 2007